Finding 406039 (2021-002)

Significant Deficiency Repeat Finding
Requirement
L
Questioned Costs
-
Year
2021
Accepted
2024-07-02
Audit: 311582
Organization: Hospital Damas INC (PR)
Auditor: Galindez LLC

AI Summary

  • Core Issue: The Hospital consistently submitted required financial reports late, violating compliance deadlines for the Coronavirus Relief Fund.
  • Impacted Requirements: Internal controls over compliance were inadequate, failing to ensure timely submission of reports as mandated by federal regulations and grant agreements.
  • Recommended Follow-up: Implement stronger monitoring and recordkeeping practices to ensure all future reports are submitted on time, addressing this repeat finding effectively.

Finding Text

Finding No. 2021-002 - Reporting Federal Program Assistance Listing 21.019 – Coronavirus Relief Fund – COVID - 19 Name of Federal Agency U.S. Department of Treasury Pass-through entity Puerto Rico Treasury Department Category Significant deficiency in internal controls over compliance / Non-compliance Compliance requirements ReportingCriteria As stated in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance), § 200.303 Internal controls, “the non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). (b) Comply with the U.S. Constitution, Federal statutes, regulations, and the terms and conditions of the Federal awards.” In addition, the grant agreement establishes in its Exhibit A of the AAFAF guidelines, Grant Plan, Reporting, the following: “By the 15th day of each month, the Grantee will submit a Use of Funds Grant Report for the prior month’s expenses. The financial report will provide a detailed explanation of how the Grant funds were spent.”Condition During our test, we identified that the Use of Funds Grant Reports that were required to be submitted by the 15th day of the following month, were submitted late, as follows:Cause The grantee did not perform effective monitoring for the compliance with the deadlines of submission and also, did not have adequate internal controls for the recordkeeping of submissions. Effect The Hospital did not submit, or did not submit on time, the financial reports that provide a detailed explanation of how the grant funds were spent and the timing of the expenditures. The analysis, evaluations, and decision-making of the grantee could be affected. Questioned cost None.Context As part of the reporting (timing) test, we examined ten (10) submission dates required, which represent the 100% of submissions required for the year for the Coronavirus Relief Fund and observed that ten (10) of the Use of Funds Grant Reports, or 100% of the required reports, were submitted after their respective due dates. Identification of a repeat finding Yes, this is a repeated finding from the immediate previous audit, finding No. 2020-002. Views of responsible officials and planned corrective actions The Hospital’s management and responsible officers agree with this finding. Please refer to the corrective action plan section for the Hospital’s response on pages 55-56.

Corrective Action Plan

Finding No. 2021-002 - Reporting Corrective Action Plan On July 29, 2022, all pending reports were submitted to AAFAF. Also, commencing immediately, Mr. José R. Rodríguez, Accounting Manager, will be de designated officer in charge of submitting the report by its due date and Mr. Julio Colón, Chief Financial Officer, will be de designated officer in charge of supervising and monitoring compliance with timely submittance each month. Name (s) of the Contact Person (s) Responsible for Corrective Action Julio Colón, Chief Financial Officer Anticipated Completion Date Completed on July 29, 2022

Categories

Subrecipient Monitoring Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties Allowable Costs / Cost Principles Reporting Significant Deficiency

Other Findings in this Audit

  • 406038 2021-001
    Significant Deficiency Repeat
  • 406040 2021-003
    Significant Deficiency Repeat
  • 406041 2021-003
    Significant Deficiency Repeat
  • 406042 2021-003
    Significant Deficiency Repeat
  • 982480 2021-001
    Significant Deficiency Repeat
  • 982481 2021-002
    Significant Deficiency Repeat
  • 982482 2021-003
    Significant Deficiency Repeat
  • 982483 2021-003
    Significant Deficiency Repeat
  • 982484 2021-003
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
21.019 Coronavirus Relief Fund $3.89M
21.027 Coronavirus State and Local Fiscal Recovery Funds $1.39M
93.498 Provider Relief Fund $1.32M